Clinical Trial Update: Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis [NA]

View source ↗

Summary

This clinical trial update investigates the use of ibuprofen to preserve lung function in patients with cystic fibrosis and notes the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Cystic Fibrosis | NA | Status: COMPLETED